EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

REV-ERBα deficiency exacerbates IL-33-mediated airway inflammation and airway hyperresponsiveness in mice

Santhosh Kumar Duraisamy, Mario Castro, Isaac Kirubakaran Sundar

Biochemical and Biophysical Research Communications · 2026-11 · 839 · 154756

DOI: 10.1016/j.bbrc.2026.154756 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemical and Biophysical Research Communications, 2026-11. Verfasst von Santhosh Kumar Duraisamy und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Division of Pulmonary Critical Care and Sleep Medicine, University of Kansas Medical Center, Kansas City, KS, USA. Hauptthemen laut MEDLINE: Nuclear Receptor Subfamily 1, Group D, Member 1, Interleukin-33, Respiratory Hypersensitivity, Asthma. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, National Institutes of Health, The University of Kansas Medical Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Asthma involves type 2 airway inflammation driven by epithelial-derived interleukin-33 (IL-33), a key mediator of allergic responses. REV-ERBα, a circadian transcriptional repressor, modulates pulmonary inflammation, but its role in IL-33-induced airway pathology remains unclear. Here we investigated IL-33-mediated pulmonary inflammation in wild-type and global Rev-erbα knockout mice exposed intranasally to recombinant IL-33. Loss of REV-ERBα markedly increased recruitment of eosinophils, neutrophils, innate lymphoid cells, and Th2 lymphocytes, exacerbated airway hyperresponsiveness, and elevated chemokines linked to type 2 inflammation. REV-ERBα deficiency also altered circadian clock protein expression, enhanced IL-33/ST2 signaling, and reduced epithelial barrier-associated proteins. These findings indicate that REV-ERBα restrains IL-33-driven airway inflammation and hyperresponsiveness, suggesting circadian mechanisms influence asthma pathogenesis and highlighting REV-ERBα as a potential therapeutic target.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nuclear Receptor Subfamily 1, Group D, Member 1Interleukin-33Respiratory HypersensitivityAsthmaPneumoniaAnimalsMice, KnockoutMiceMice, Inbred C57BLSignal TransductionInflammation

Stichwörter der Autor:innen

Airway hyperresponsivenessAirway inflammationAsthmaCircadian clockIL-33/ST2 signalingREV-ERBα/NR1D1Type 2 immunity

Substanzen

Nuclear Receptor Subfamily 1, Group D, Member 1Interleukin-33Nr1d1 protein, mouseIl33 protein, mouse

Autor:innen und Institutionen

  • Department of Internal Medicine, Division of Pulmonary Critical Care and Sleep Medicine, University of Kansas Medical Center, Kansas City, KS, USA.
  • Department of Internal Medicine, Division of Pulmonary Critical Care and Sleep Medicine, University of Kansas Medical Center, Kansas City, KS, USA. Electronic address: isundar@kumc.edu.

Förderung

  • NHLBI NIH HHS
  • National Institutes of Health
  • The University of Kansas Medical Center

Zitieren

APA

Duraisamy, S. K., Castro, M., & Sundar, I. K. (2026). REV-ERBα deficiency exacerbates IL-33-mediated airway inflammation and airway hyperresponsiveness in mice. Biochemical and Biophysical Research Communications, 839, 154756. https://doi.org/10.1016/j.bbrc.2026.154756

Vancouver

Duraisamy SK, Castro M, Sundar IK. REV-ERBα deficiency exacerbates IL-33-mediated airway inflammation and airway hyperresponsiveness in mice. Biochemical and Biophysical Research Communications. 2026;839:154756. doi:10.1016/j.bbrc.2026.154756

BibTeX
@article{Duraisamy2026,
  author = {Duraisamy, Santhosh Kumar and Castro, Mario and Sundar, Isaac Kirubakaran},
  title = {REV-ERBα deficiency exacerbates IL-33-mediated airway inflammation and airway hyperresponsiveness in mice},
  journal = {Biochemical and Biophysical Research Communications},
  year = {2026},
  volume = {839},
  pages = {154756},
  doi = {10.1016/j.bbrc.2026.154756}
}
Kostenlos starten →